@nanospectra.com
Nanospectra Biosciences develops particle-based therapies for the selective and precise thermal destruction of solid tumors.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
Nanospectra Biosciences is a pioneering medical device company that leverages nanoshells to deliver the first true focal therapy. Their proprietary ultra-focal technology platform, AuroLase®, utilizes 'optical tunability' to convert light into heat, effectively destroying solid tumors while minimizing damage to healthy tissue. This breakthrough therapy, demonstrated through initial clinical trials, offers a patient-centric approach to selective thermal ablation.
Nanospectra's AuroLase® is designed to maximize treatment efficacy and minimize the side effects commonly associated with surgery, radiation, and traditional focal therapies. With its success in treating prostate cancer tissue, AuroLase® is poised to make a significant impact in the field of oncology. To advance their innovative technology, Nanospectra is implementing a multi-prong growth strategy that includes clinical advancements, exclusive partnerships, and ongoing research and development.
They are committed to delivering on the 'Nanomedicine Promise' by offering safe and effective solutions for solid tumors, tissue, and drug delivery. Stay up-to-date with Nanospectra's latest news, press releases, and clinical trial information to learn more about their groundbreaking advancements in nanomedicine
Company Type
Privately Held
Company Size
2-10
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online